Literature DB >> 26996958

Determination of anti-tuberculosis drug concentration and distribution from sustained release microspheres in the vertebrae of a spinal tuberculosis rabbit model.

Peng Liu1, Hui Jiang2, Shijun Li1, Zhen Lin2, Jianming Jiang2.   

Abstract

There have been several sustained-release materials containing anti-tuberculosis drug to enhance concentration in foci of spinal tuberculosis but what map by which composite drug delivery system is released is not known. Isoniazid (INH) lactic-co-glycolic acid (PLGA) and INH hydroxyapatite (HA) microspheres were prepared, respectively. The rabbits were modeled by tuberculosis strains and sustained-release microspheres were incubated in the foci. INH concentrations in the HA group were higher than those of INH and PLGA groups at L3, L4, and L5 vertebra 2 days after the drugs were embedded (p < 0.05). INH concentrations in the HA group were higher than those of INH and PLGA groups in L3 vertebra 4 days after the drugs were embedded (p < 0.05). INH concentrations in the PLGA group were higher than those of INH and HA groups in L5 vertebra; INH concentrations of the HA group were higher than those of INH and PLGA groups in L4 vertebra 6 days after the drugs were embedded (p < 0.05). These microspheres can enhance INH concentration in the foci. Furthermore, HA microspheres elicit osteogenic effects. HA is better than PLGA in terms of infiltration, but PLGA is better than HA in terms of distribution.
© 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:200-208, 2017. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  anti-tuberculosis drugs; spinal tuberculosis; sustained-release

Mesh:

Substances:

Year:  2016        PMID: 26996958     DOI: 10.1002/jor.23236

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  4 in total

1.  New horizons in spine research: Intervertebral disc repair and regeneration.

Authors:  James C Iatridis; James Kang; Rita Kandel; Makarand V Risbud
Journal:  J Orthop Res       Date:  2017-01       Impact factor: 3.494

2.  Rifapentine Polylactic Acid Sustained-Release Microsphere Complex for Spinal Tuberculosis Therapy: Preparation, in vitro and in vivo Studies.

Authors:  Zhen Wang; Xinghua Song; Abulikemu Maimaitiaili; Tengfei Wang
Journal:  Infect Drug Resist       Date:  2021-05-14       Impact factor: 4.003

Review 3.  The wide utility of rabbits as models of human diseases.

Authors:  Pedro J Esteves; Joana Abrantes; Hanna-Mari Baldauf; Lbachir BenMohamed; Yuxing Chen; Neil Christensen; Javier González-Gallego; Lorenzo Giacani; Jiafen Hu; Gilla Kaplan; Oliver T Keppler; Katherine L Knight; Xiang-Peng Kong; Dennis K Lanning; Jacques Le Pendu; Ana Lemos de Matos; Jia Liu; Shuying Liu; Ana M Lopes; Shan Lu; Sheila Lukehart; Yukari C Manabe; Fabiana Neves; Grant McFadden; Ruimin Pan; Xuwen Peng; Patricia de Sousa-Pereira; Ana Pinheiro; Masmudur Rahman; Natalie Ruvoën-Clouet; Selvakumar Subbian; Maria Jesús Tuñón; Wessel van der Loo; Michael Vaine; Laura E Via; Shixia Wang; Rose Mage
Journal:  Exp Mol Med       Date:  2018-05-22       Impact factor: 8.718

Review 4.  Animal models of tuberculosis: Lesson learnt.

Authors:  Amit Kumar Singh; Umesh D Gupta
Journal:  Indian J Med Res       Date:  2018-05       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.